EcoDrugPlus

Ensembl ID : ML149637a
Gene Symbol: -
External references: -
259 Possible Orthologues:

Ensembl ID : ML150010a
Gene Symbol: -
External references: -
464 Possible Orthologues:

Ensembl ID : ML150012a
Gene Symbol: -
External references: -
463 Possible Orthologues:

Ensembl ID : ML150013a
Gene Symbol: -
External references: -
464 Possible Orthologues:

Ensembl ID : ML150014a
Gene Symbol: -
External references: -
461 Possible Orthologues:

Ensembl ID : ML150419a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML150420a
Gene Symbol: -
External references: -
309 Possible Orthologues:

Ensembl ID : ML150910a
Gene Symbol: -
External references: -
299 Possible Orthologues:

Ensembl ID : ML150911a
Gene Symbol: -
External references: -
299 Possible Orthologues:

Ensembl ID : ML15153a
Gene Symbol: -
External references: -
129 Possible Orthologues:

Ensembl ID : ML15195a
Gene Symbol: -
External references: -
184 Possible Orthologues:

Ensembl ID : ML154145a
Gene Symbol: -
External references: -
738 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).